The AIDS Healthcare Foundation (AHF), a prominent nonprofit known for its extensive involvement in healthcare and housing, is at the center of a new legislative development in California. In 2024, voters narrowly approved Proposition 34, which mandates that participants in the federal 340B Drug Pricing Program allocate at least 98 percent of their associated revenue to direct patient care. This measure appears specifically targeted at AHF, given its substantial pharmacy operations and controversial political activities.
AHF’s annual revenue reaches nearly $2.3 billion, with over 92 percent stemming from its pharmacy operations under the 340B program. The organization has been using these funds not only for healthcare but also to support its housing initiatives. It operates low-income multifamily housing units and has invested over $100 million in ballot measures aimed at expanding rent control in California.
Michael Weinstein, AHF’s president, has been described by Politico as an “anti-MAGA progressive savior” due to his efforts to reshape California’s rental economy through ballot measures. Despite significant financial backing, these initiatives have consistently failed to gain voter approval.
Proposition 34 could significantly impact AHF’s operations if it withstands legal challenges. The measure requires strict adherence to spending guidelines under the 340B program, potentially threatening AHF’s state tax-exempt status and healthcare licenses if not followed.
The foundation’s approach to homelessness—viewed through a left-of-center ideological lens—has drawn criticism for possibly limiting the effectiveness of addressing the issue. Critics argue that while AHF links homelessness directly to affordable housing shortages, their advocacy for rent control might exacerbate housing supply issues.
As this situation unfolds, it highlights the complex interplay between federal funding programs and local policy activism amid California’s ongoing homelessness crisis.
